These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 34095244)

  • 1. Association Between Anticoagulation Outcomes and Venous Thromboembolism History in Chronic Thromboembolic Pulmonary Hypertension.
    Zhu YJ; Zhou YP; Wei YP; Xu XQ; Yan XX; Liu C; Zhu XJ; Liu ZY; Sun K; Hua L; Jiang X; Jing ZC
    Front Cardiovasc Med; 2021; 8():628284. PubMed ID: 34095244
    [No Abstract]   [Full Text] [Related]  

  • 2. The anticoagulant effects of warfarin and the bleeding risk associated with its use in patients with chronic thromboembolic pulmonary hypertension at a specialist center in Japan: a retrospective cohort study.
    Jujo-Sanada T; Tanabe N; Sakao S; Sugiura T; Sekine A; Nishimura R; Suda R; Naito A; Miwa H; Yamamoto K; Sasaki A; Matsumura A; Ema R; Kasai H; Kato F; Tatsumi K
    Pulm Circ; 2017; 7(3):684-691. PubMed ID: 28604280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct oral anticoagulants in the treatment of chronic thromboembolic pulmonary hypertension patients: A retrospective cohort study.
    Chong LT; Hu S; Guo TT; Gao X; Tan JS; Liu ZQ; Deng YR; Wei YX; Hua L
    Respir Med; 2024 Jun; 231():107722. PubMed ID: 38936635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-life data of direct anticoagulant use, bleeding risk and venous thromboembolism recurrence in chronic thromboembolic pulmonary hypertension patients: an observational retrospective study.
    Sena S; Bulent M; Derya K; Deniz K; Halil A; Okan E; Bedrettin Y
    Pulm Circ; 2020; 10(1):2045894019873545. PubMed ID: 32128155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer.
    Akl EA; Kahale L; Barba M; Neumann I; Labedi N; Terrenato I; Sperati F; Muti P; Schünemann H
    Cochrane Database Syst Rev; 2014 Jul; (7):CD006650. PubMed ID: 25004410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicenter study of anticoagulation in operable chronic thromboembolic pulmonary hypertension.
    Bunclark K; Newnham M; Chiu YD; Ruggiero A; Villar SS; Cannon JE; Coghlan G; Corris PA; Howard L; Jenkins D; Johnson M; Kiely DG; Ng C; Screaton N; Sheares K; Taboada D; Tsui S; Wort SJ; Pepke-Zaba J; Toshner M
    J Thromb Haemost; 2020 Jan; 18(1):114-122. PubMed ID: 31557382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tinzaparin vs Warfarin for Treatment of Acute Venous Thromboembolism in Patients With Active Cancer: A Randomized Clinical Trial.
    Lee AYY; Kamphuisen PW; Meyer G; Bauersachs R; Janas MS; Jarner MF; Khorana AA;
    JAMA; 2015 Aug; 314(7):677-686. PubMed ID: 26284719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer.
    Akl EA; Labedi N; Barba M; Terrenato I; Sperati F; Muti P; Schünemann H
    Cochrane Database Syst Rev; 2011 Jun; (6):CD006650. PubMed ID: 21678361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case-fatality of recurrent venous thromboembolism and major bleeding associated with aspirin, warfarin, and direct oral anticoagulants for secondary prevention.
    Wu C; Alotaibi GS; Alsaleh K; Linkins LA; McMurtry MS
    Thromb Res; 2015 Feb; 135(2):243-8. PubMed ID: 25488466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of Outcomes Among Patients With Venous Thromboembolism With and Without Chronic Kidney Disease.
    Goto S; Haas S; Ageno W; Goldhaber SZ; Turpie AGG; Weitz JI; Angchaisuksiri P; Nielsen JD; Kayani G; Farjat A; Schellong S; Bounameaux H; Mantovani LG; Prandoni P; Kakkar AK;
    JAMA Netw Open; 2020 Oct; 3(10):e2022886. PubMed ID: 33112399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and Risk Factors of Recurrent Venous Thromboembolism after Pulmonary Embolism.
    Hwang HG; Choi WI; Lee B; Lee CW
    Tuberc Respir Dis (Seoul); 2019 Oct; 82(4):341-347. PubMed ID: 31172708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticoagulation for the long term treatment of venous thromboembolism in patients with cancer.
    Akl EA; Barba M; Rohilla S; Terrenato I; Sperati F; Muti P; Schünemann HJ
    Cochrane Database Syst Rev; 2008 Apr; (2):CD006650. PubMed ID: 18425959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness and safety of rivaroxaban versus warfarin for treatment and prevention of recurrence of venous thromboembolism.
    Coleman CI; Bunz TJ; Turpie AGG
    Thromb Haemost; 2017 Oct; 117(10):1841-1847. PubMed ID: 28640322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duration of anticoagulation following venous thromboembolism: a meta-analysis.
    Ost D; Tepper J; Mihara H; Lander O; Heinzer R; Fein A
    JAMA; 2005 Aug; 294(6):706-15. PubMed ID: 16091573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness and safety of rivaroxaban and warfarin in patients with unprovoked venous thromboembolism: a propensity-matched nationwide cohort study.
    Larsen TB; Skjøth F; Kjældgaard JN; Lip GYH; Nielsen PB; Søgaard M
    Lancet Haematol; 2017 May; 4(5):e237-e244. PubMed ID: 28411120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety, effectiveness, and health care cost comparisons among elderly patients with venous thromboembolism prescribed warfarin or apixaban in the United States Medicare population.
    Hlavacek P; Guo JD; Rosenblatt L; Keshishian A; Russ C; Mardekian J; Ferri M; Poretta T; Yuce H; McBane R
    Curr Med Res Opin; 2019 Dec; 35(12):2043-2051. PubMed ID: 31387467
    [No Abstract]   [Full Text] [Related]  

  • 17. Balancing risks of recurrent venous thromboembolism and bleeding with extended anticoagulation: a decision analysis.
    de Winter MA; Thavorn K; Hageman SHJ; Nijkeuter M; Wells PS
    Res Pract Thromb Haemost; 2024 Jan; 8(1):102274. PubMed ID: 38222076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The risks of thromboembolism vs. recurrent gastrointestinal bleeding after interruption of systemic anticoagulation in hospitalized inpatients with gastrointestinal bleeding: a prospective study.
    Sengupta N; Feuerstein JD; Patwardhan VR; Tapper EB; Ketwaroo GA; Thaker AM; Leffler DA
    Am J Gastroenterol; 2015 Feb; 110(2):328-35. PubMed ID: 25512338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of recurrent venous thromboembolism in patients with HIV infection: A nationwide cohort study.
    Rokx C; Borjas Howard JF; Smit C; Wit FW; Pieterman ED; Reiss P; Cannegieter SC; Lijfering WM; Meijer K; Bierman W; Tichelaar V; Rijnders BJA;
    PLoS Med; 2020 May; 17(5):e1003101. PubMed ID: 32407386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk Factors for Major Bleeding during Prolonged Anticoagulation Therapy in Patients with Venous Thromboembolism: From the COMMAND VTE Registry.
    Kim K; Yamashita Y; Morimoto T; Kitai T; Yamane T; Ehara N; Kinoshita M; Kaji S; Amano H; Takase T; Hiramori S; Oi M; Akao M; Kobayashi Y; Toyofuku M; Izumi T; Tada T; Chen PM; Murata K; Tsuyuki Y; Saga S; Sasa T; Sakamoto J; Kinoshita M; Togi K; Mabuchi H; Takabayashi K; Shiomi H; Kato T; Makiyama T; Ono K; Furukawa Y; Kimura T;
    Thromb Haemost; 2019 Sep; 119(9):1498-1507. PubMed ID: 31230344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.